Status: Recruiting
Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
This phase I trial investigates the effects of influenza vaccine in treating patients with stage I-IV melanoma. While intramuscular administration of influenza vaccine provides immunization against the influenza virus, giving influenza vaccine directly into the tumor (intralesional) may decrease the size of the injected melanoma tumor, or the extent of the melanoma within the body.
Participants needed: 36
Trial details
Phase: Phase 1Age: 18-99Biological sex: AllType: InterventionalSponsor: Carlo ContrerasUpdated: Jul 13, 2026Locations: 1
Eligibility criteria
Males or females [+26]
Known allergy or intolerance to influenza vaccination [+9]